• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

How Can Anti-wrinkle Injections Be The Safest Treatment in Aesthetic Medicine - And Yet Paradoxically the Most Dangerous ?

Botulinum Toxin - The Safest Treatment in Aesthetic Medicine, and the Most Dangerous A - Tale of Two Realities.

8 million cosmetic botulinum toxin are every year. The safety record of this licensed is extraordinary. The story of unlicensed use is the complete . why the two are so different is one of the most important in aesthetic medicine.

The numbers that define the landscape

Botulinum toxin is the most performed non-surgical aesthetic procedure in the world, by a margin.

According to the ISAPS 2024 Global Survey, 7.8 million botulinum toxin were performed by plastic globally in 2024 alone, with the American of Plastic Surgeons reporting 7.4 in the United States alone. These figures cover only procedures performed by plastic surgeons; the true global volume, encompassing dermatologists, aesthetic physicians, and other qualified medical practitioners, is higher.

conservatively from growth data, the number of botulinum toxin rose by 459% from 2000 to 2020, with FDA cosmetic approval in 2002. toxin treatments since approval sit conservatively in the region of 150 to 200 procedures, and may be considerably more.

It is, by any measure, one of the most administered in human .

Against that background, the safety record of licensed use is extraordinary. And the safety record of unlicensed use is the opposite.

The licensed safety record — what the data actually shows

The most early of toxin adverse events in cosmetic use examined all FDA adverse event reports over the 13.5 years following licensure — from December 1989 to May 2003.

Among cosmetic users, no deaths were . Of the 36 serious adverse events across the entire review period, 30 were included as possible outcomes in the FDA-approved label. The remaining six serious adverse events did not a pattern suggesting a common causal relationship to toxin.

To that figure: in 2002 alone there were approximately 1.1 to 1.6 cosmetic toxin users in the United States. Across 13.5 years of FDA reporting, 36 serious adverse events in cosmetic use — 30 of which were already known and — represents a event rate that most medical would find to match.

Death after botulinum toxin for cosmetic has never been with approved formulations. This is not a qualified statement. It is an absolute one, and it has held across more than three of widespread global use.

What those 30 recognised complications actually were

Understanding what the 30 "recognised complications" represent is important the phrase might imply a catalogue of serious harms, when in fact it reflects something considerably more .

The FDA-approved label for Botox Cosmetic lists the known possible complications established during trials before the product was approved. These include local effects, principally ptosis and brow ptosis, in which the toxin slightly beyond the intended site and muscles. Both are distressing for the patient and with correct technique, but both are temporary and always resolve as the wears off.

The FDA label that the effects of Botox Cosmetic may spread from the area of injection to produce symptoms consistent with toxin effects, generalised muscle weakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, incontinence, and difficulties, reported hours to weeks after . In use at standard aesthetic doses, this spread is rare but it is a recognised possibility that clinical trial data identified, that practitioners are to and manage, and that the consent is supposed to cover. Several of the 30 serious events in use were presentations of exactly this kind.

reactions — anaphylaxis, urticaria, soft tissue oedema — are also listed as possible serious reactions. One fatal case of anaphylaxis has been reported in which lidocaine, used as a diluent, was the cause rather than the botulinum toxin itself. This single death, attributed to the rather than the toxin, is the the cosmetic record has come to a fatality and it was not caused by the botulinum toxin.

The therapeutic use comparison — and why it matters

The contrast with botulinum toxin use is clinically . Among therapeutic users over the same 13.5 year period, 217 serious adverse events were identified, including all 28 reported deaths. Every death associated with toxin in the FDA review occurred in medical use rather than use.

The explanation is straightforward. applications — dystonia, spasticity, — require doses that are an order of magnitude higher than those used in aesthetic .

The patients receiving them frequently have complex medical and neurological conditions, impaired swallowing mechanisms, or reduced respiratory reserve that makes systemic toxin spread more dangerous. The doses used for OnabotulinumtoxinAAbobotulinumtoxinAIncobotulinumtoxinAPrabotulinumtoxinALetibotulinumtoxinARimabotulinumtoxinBHyaluronic Acid FillersCalcium Hydroxylapatite FillersPoly-L-lactic Acid FillersPolymethylmethacrylate FillersAutologous Fat GraftingForehead Lines TreatmentGlabellar Frown Lines TreatmentCrow's Feet TreatmentBunny Lines TreatmentChemical Brow LiftLip FlipGummy Smile CorrectionMasseter ReductionJaw SlimmingDimpled Chin SmoothingCobblestone Chin SmoothingNefertiti Neck LiftMicro-BotoxMesotoxHyperhidrosis TreatmentChronic Migraine ReliefBruxism TreatmentTMJ TreatmentCervical Dystonia TreatmentNeck Spasm TreatmentBlepharospasm TreatmentLip AugmentationLip ContouringCheekbone EnhancementTear Trough FillersNasolabial Fold SofteningMarionette Line FillersLiquid RhinoplastyNon-Surgical Nose JobJawline ContouringJawline DefinitionChin AugmentationTemple VolumisingHand RejuvenationAcne Scar Subcision Filling, crow's feet, and forehead treatment are minute by — and they are into healthy tissue in otherwise well patients.

The distinction matters because it is sometimes cited, incorrectly, as that botulinum toxin a significant death risk in aesthetic use. It does not. The death data and the cosmetic safety data belong to entirely different clinical contexts, and conflating them both.

The unlicensed reality — a very different story

Against the safety record of licensed use, the story of unlicensed toxin is a study in . A CDC investigation 17 confirmed cases across 9 US states, with 13 hospitalisations, linked to counterfeit or botulinum toxin products — some from unlicensed individuals, some through online marketplaces, and some self-injected.

Symptoms in cases or double vision, difficulty swallowing, difficulty breathing, and slurred speech — consistent with systemic botulism from doses of laboratory-grade toxin rather than the precisely formulated, licensed product. 

medical providers have safely administered toxin for . However, unsafe use, products, administration by providers, or self-injection, has resulted in severe illnesses, with some patients requiring mechanical ventilation in an Care setting.

The FDA issued warning letters to 18 companies or botulinum toxin online. By 2025, the CDC was reporting additional cases of severe following self-injection of from online retailers, a trend that shows no sign of as long as the remain accessible through .

Why the contrast exists — the science of the safety difference

The contrast between licensed and unlicensed toxin safety is not a abstraction. It has a scientific .

Licensed botulinum toxin e.g. Botox, Dysport, Xeomin, and their equivalents are pharmaceutical-grade preparations in which the of active neurotoxin is precisely characterised, standardised, and in units that allow to a known and accurately controlled dose. The of one unit of onabotulinumtoxinA (Botox) is defined against a mouse lethality assay. The dose ranges used in medicine have been established through trials as to produce the desired local muscle relaxation with an adequate safety margin against spread.

or laboratory-grade toxin, whether sourced from unregulated online suppliers, research chemical vendors, or fraudulent distributors, has no such standardisation. The of active toxin is unknown and . The formulation may be for . The storage, transport, and handling that may have been violated. And the person administering it may have no of dose-response relationships, no of facial anatomy, and no to recognise or manage a complication.

Botulinum toxin is, in its raw form, one of the most potent toxins known to science. The aesthetic product is the same molecule, safe by precision, formulation, standardised dosing, and delivery by trained medical who understand both its mechanism and its risks. Remove any of those and you are not administering a precision . You are administering an uncharacterised biological toxin.

The clinical and regulatory implications

The botulinum toxin safety data makes an argument that is almost impossible to counter on its merits: the product, in hands, is safe to a degree that is genuinely remarkable and unmatched by almost every other licensed medicine.

However, the product outside of that framework is potentially highly . The difference between those two is not the molecule. It is everything that it, namely the pharmaceutical standards, the regulatory approval, the clinical training, the knowledge, the consent process, and the capacity to manage when they arise.

This is the same argument we have made throughout this blog in different registers: about the Wild West of UK aesthetics regulation, about the practitioner who cannot manage a vascular occlusion, about the between a qualified doctor and a weekend certificate holder. The botulinum toxin data provides perhaps the clearest and most compelling evidence base for that argument of anything we have examined.

References

Coté TR et al. Botulinum toxin type A injections: adverse events reported to the US Food and Drug in therapeutic and cases.  of the American Academy of . 2005;53(3):407–415. 

ISAPS Global Survey 2024. International Society of Plastic Surgery. 

CDC Investigation: Reactions to Toxin Injections. Centers for Disease Control and Prevention. 2024. 

FDA Alert: Counterfeit Version of Botox Found in States. US Food and Drug . 2024. 

CDC MMWR: Severe Illnesses After of Botulinum Toxin Purchased Online. 2025. 

Nayyar P et al. Toxin Deaths: What is the Fact?  of Maxillofacial and Oral Surgery. 2008. 

FDA Information: Botox Cosmetic (onabotulinumtoxinA). 

In The UK Why Do We Have 140 licensed Dermal Fillers Whereas there are only 25 in the USA ?

Zein Obagi - Our Skin Hero

6 Esher Park Avenue
Esher, Surrey KT10 9NP

Tel: ‬
Tel: ‭ ‬

© 2026
The Cosmetic Ltd
Company no.